Equities research analysts at BNP Paribas Exane began coverage on shares of XPeng (NYSE:XPEV - Get Free Report) in a research report issued on Monday, MarketBeat reports. The brokerage set a "neutral" rating and a $19.00 price target on the stock. BNP Paribas Exane's price target suggests a potential downside of 6.79% from the stock's current price.
Other research analysts also recently issued research reports about the company. The Goldman Sachs Group raised XPeng from a "neutral" rating to a "buy" rating and upped their price objective for the company from $16.40 to $24.00 in a research note on Tuesday, June 17th. Sanford C. Bernstein set a $19.00 price objective on XPeng and gave the company a "market perform" rating in a research note on Thursday, May 22nd. BNP Paribas initiated coverage on XPeng in a research note on Monday. They issued a "neutral" rating for the company. Morgan Stanley set a $28.00 price objective on XPeng and gave the company an "overweight" rating in a research note on Thursday, June 12th. Finally, Macquarie upped their price objective on XPeng from $24.00 to $25.00 and gave the company an "outperform" rating in a research note on Friday, August 15th. One analyst has rated the stock with a Strong Buy rating, eight have issued a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, XPeng has a consensus rating of "Moderate Buy" and an average target price of $23.85.
Read Our Latest Stock Report on XPeng
XPeng Price Performance
NYSE XPEV traded down $0.3560 during trading on Monday, hitting $20.3840. 5,983,735 shares of the company's stock were exchanged, compared to its average volume of 7,391,799. The company has a current ratio of 1.21, a quick ratio of 1.07 and a debt-to-equity ratio of 0.34. The company has a market cap of $19.35 billion, a PE ratio of -32.36 and a beta of 2.50. XPeng has a fifty-two week low of $6.75 and a fifty-two week high of $27.16. The stock's 50 day moving average price is $18.80 and its two-hundred day moving average price is $19.47.
XPeng (NYSE:XPEV - Get Free Report) last issued its earnings results on Wednesday, May 21st. The company reported ($0.10) EPS for the quarter, topping the consensus estimate of ($1.51) by $1.41. The firm had revenue of $2.18 billion during the quarter, compared to the consensus estimate of $15.80 billion. XPeng had a negative return on equity of 13.65% and a negative net margin of 7.14%. Research analysts expect that XPeng will post -0.96 EPS for the current year.
Institutional Trading of XPeng
Institutional investors have recently added to or reduced their stakes in the stock. Farther Finance Advisors LLC boosted its holdings in XPeng by 70.1% in the first quarter. Farther Finance Advisors LLC now owns 1,291 shares of the company's stock valued at $27,000 after acquiring an additional 532 shares during the last quarter. Atlas Capital Advisors Inc. boosted its holdings in XPeng by 651.0% in the first quarter. Atlas Capital Advisors Inc. now owns 1,502 shares of the company's stock valued at $31,000 after acquiring an additional 1,302 shares during the last quarter. Garde Capital Inc. bought a new position in shares of XPeng during the 1st quarter worth approximately $39,000. Natixis bought a new position in shares of XPeng during the 4th quarter worth approximately $43,000. Finally, SVB Wealth LLC bought a new position in shares of XPeng during the 1st quarter worth approximately $46,000. 21.09% of the stock is currently owned by institutional investors.
XPeng Company Profile
(
Get Free Report)
XPeng Inc designs, develops, manufactures, and markets smart electric vehicles (EVs) in the People's Republic of China. It offers SUVs under the G3, G3i, and G9 names; four-door sports sedans under the P7 and P7i names; and family sedans under the P5 name. The company also provides sales contracts, super charging, maintenance, technical support, auto financing, insurance, technology support, ride-hailing, automotive loan referral, and other services, as well as vehicle leasing and insurance agency services.
Featured Stories

Before you consider XPeng, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and XPeng wasn't on the list.
While XPeng currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.